Taisho Pharmaceutical Holdings Co., Ltd.
TAISF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $29 | $21 | $23 | $30 |
| Dep. & Amort. | $25 | $23 | $22 | $17 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1 | $2 | $3 | $7 |
| Other Non-Cash | -$12 | -$18 | -$6 | -$12 |
| Operating Cash Flow | $41 | $29 | $42 | $42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$50 | -$14 | -$14 | -$9 |
| Net Acquisitions | $2 | -$4 | -$4 | -$160 |
| Inv. Purchases | -$3 | -$1 | -$2 | -$2 |
| Inv. Sales/Matur. | $7 | $9 | $14 | $75 |
| Other Inv. Act. | $18 | $4 | $5 | -$10 |
| Investing Cash Flow | -$27 | -$7 | -$2 | -$107 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $2 | $3 | -$1 |
| Stock Repurch. | -$0 | -$0 | -$0 | -$0 |
| Dividends Paid | -$8 | -$7 | -$9 | -$10 |
| Other Fin. Act. | -$3 | -$3 | -$3 | -$2 |
| Financing Cash Flow | -$11 | -$10 | -$11 | -$12 |
| Forex Effect | $2 | $1 | -$0 | $0 |
| Net Chg. in Cash | $5 | $12 | $28 | -$77 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $228 | $215 | $187 | $264 |
| End Cash | $232 | $228 | $215 | $187 |
| Free Cash Flow | -$9 | $14 | $28 | $33 |